Kimberly Lezon-Geyda

1.4k citations

34 papers · 860 indexed · h-index 16

Co-authors: Vincent Schulz Patrick G. Gallagher Yelena Maksimova Lyndsay N. Harris Edyta Glogowska Vesna Najfeld EM Johnson David Tuck
Topics: Erythrocyte Function and Pathophysiology (10 papers)HER2/EGFR in Cancer Research (6 papers)Genomics and Chromatin Dynamics (6 papers)
Cited by: Cancer Research Hematology Genetics
Journals: Nucleic Acids Research Circulation Journal of Clinical Investigation
Partner nations: United States Germany Australia

In The Last Decade

Kimberly Lezon-Geyda

32 papers receiving 853 citations

Peers

Countries citing papers authored by Kimberly Lezon-Geyda

Since Specialization

Citations

This map shows the geographic impact of Kimberly Lezon-Geyda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Lezon-Geyda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Lezon-Geyda more than expected).

Fields of papers citing papers by Kimberly Lezon-Geyda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Lezon-Geyda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Lezon-Geyda. The network helps show where Kimberly Lezon-Geyda may publish in the future.

Co-authorship network of co-authors of Kimberly Lezon-Geyda

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Lezon-Geyda. A scholar is included among the top collaborators of Kimberly Lezon-Geyda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Lezon-Geyda. Kimberly Lezon-Geyda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity 2022 ·Circulation ·Raja Chakraborty,Allison C. Ostriker,Yi Xie,Jui M. Dave,Ana María Gámez-Méndez,Payel Chatterjee,(unknown),(unknown),Kimberly Lezon-Geyda,Daniel M. Greif,Vincent Schulz,Patrick G. Gallagher,William C. Sessa,John Hwa,Kathleen A. Martin	60
2	Regulation of RNA polymerase II activity is essential for terminal erythroid maturation 2021 ·Blood ·Zachary C. Murphy,Kristin Murphy,Jacquelyn Myers,Michael Getman,(unknown),Vincent Schulz,Kimberly Lezon-Geyda,(unknown),Hongxia Yan,Narla Mohandas,Patrick G. Gallagher,Laurie A. Steiner	14
3	Aberrant splicing contributes to severe α-spectrin–linked congenital hemolytic anemia 2019 ·Journal of Clinical Investigation ·Patrick G. Gallagher,Yelena Maksimova,Kimberly Lezon-Geyda,Peter E. Newburger,Desiree Medeiros,Robin Hanson,Jennifer Rothman,Sara J. Israels,Donna A. Wall,Robert F. Sidonio,Colin A. Sieff,(unknown),Nupur Mittal,(unknown),David W. Speicher,Susan J. Baserga,Vincent Schulz	19
4	A Unique Epigenomic Landscape Defines Human Erythropoiesis 2019 ·Cell Reports ·Vincent Schulz,Hongxia Yan,Kimberly Lezon-Geyda,Xiuli An,John Hale,Christopher D. Hillyer,Narla Mohandas,Patrick G. Gallagher	41
5	Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis 2017 ·Pediatric Blood & Cancer ·Elizabeth Yang,(unknown),Kimberly Lezon-Geyda,Vincent Schulz,Patrick G. Gallagher	11
6	CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 2016 ·PLoS ONE ·Laurie A. Steiner,Vincent Schulz,(unknown),Kimberly Lezon-Geyda,Patrick G. Gallagher	6
7	Brief‐exposure to preoperative bevacizumab reveals a TGF‐β signature predictive of response in HER2‐negative breast cancers 2015 ·International Journal of Cancer ·Vinay Varadan,Sitharthan Kamalakaran,Hannah Gilmore,Nilanjana Banerjee,Angel Janevski,Kristy Miskimen,Nicole Williams,(unknown),Anant Madabhushi,Kimberly Lezon-Geyda,Veerle Bossuyt,Donald R. Lannin,Maysa Abu‐Khalaf,William M. Sikov,Nevenka Dimitrova,Lyndsay N. Harris	14
8	Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy 2015 ·Breast Cancer Research and Treatment ·(unknown),Christos Hatzis,Gina G. Chung,(unknown),Kimberly Lezon-Geyda,Daniel Zelterman,Michael P. DiGiovanna,Lyndsay N. Harris,Maysa Abu‐Khalaf	25
9	Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes 2014 ·Blood ·Jason S. Weinstein,Kimberly Lezon-Geyda,Yelena Maksimova,Samuel Craft,(unknown),Mack Y. Su,Vincent Schulz,Joseph Craft,Patrick G. Gallagher	39
10	A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer 2014 ·BMC Cancer ·(unknown),David W. Salzman,Deirdre Wall,(unknown),(unknown),Catherine Sullivan,Robert Lindner,Catherine Curran,Kimberly Lezon-Geyda,Terri McVeigh,Lyndsay N. Harris,John Newell,Michael J. Kerin,Marie Wood,Nicola Miller,Joanne B. Weidhaas	12
11	Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia 2013 ·Bone ·Subhash C. Juneja,Alin Vonica,Caroline J. Zeiss,Kimberly Lezon-Geyda,Bogdan Yatsula,David R. Sell,Vincent M. Monnier,Sharon Lin,Thomas Ardito,David R. Eyre,David G. Reynolds,Zhenqiang Yao,Hani A. Awad,Hongbo Yu,Michael P. Wilson,Sylvie Honnons,Brendan F. Boyce,Lianping Xing,Yi Zhang,Archibald S. Perkins	17
12	Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy 2013 ·PLoS ONE ·Robert Lindner,(unknown),(unknown),Kimberly Lezon-Geyda,(unknown),Neal Fischbach,Mansi Shah,Veerle Bossuyt,Vincent Schulz,David Tuck,Lyndsay N. Harris	68
13	The Patient With Transfusion-Dependent Anemia: Diagnosis and Directed Management With Targeted Next Generation Sequencing and Copy Number Analysis 2013 ·Blood ·Vincent Schulz,Yelena Maksimova,Kimberly Lezon-Geyda,Patrick G. Gallagher	0
14	Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer 2012 ·Breast Cancer Research and Treatment ·Veronique Neumeister,Catherine Sullivan,Robert Lindner,Kimberly Lezon-Geyda,Jia Li,J Závada,Maritza Martel,Peter M. Glazer,David Tuck,David L. Rimm,Lyndsay N. Harris	45
15	Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens. 2011 ·Journal of Clinical Oncology ·Sitharthan Kamalakaran,Kimberly Lezon-Geyda,Vinay Varadan,Nilanjana Banerjee,Donald R. Lannin,Tina Rizack,William M. Sikov,Maysa Abu‐Khalaf,Angel Janevski,Lyndsay N. Harris	2
16	GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays 2011 ·Nucleic Acids Research ·Ao Li,Zongzhi Liu,Kimberly Lezon-Geyda,Sudipa Sarkar,Donald R. Lannin,Vincent Schulz,Ian E. Krop,Eric P. Winer,Lyndsay N. Harris,David Tuck	67
17	PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function 2011 ·Blood ·Yi Zhang,Sandra Stehling-Sun,Kimberly Lezon-Geyda,Subhash C. Juneja,(unknown),Gouri Chatterjee,Charles A. Wuertzer,Fernando D. Camargo,Archibald S. Perkins	81
18	Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera 2003 ·Experimental Hematology ·Vesna Najfeld,Shai Fuchs,(unknown),Kimberly Lezon-Geyda,Steven Fruchtman	4
19	Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia 2001 ·Leukemia ·Kimberly Lezon-Geyda,Vesna Najfeld,EM Johnson	57
20	Chrysotile asbestos fibers mediate homologous recombination in Rat2λ fibroblasts: implications for carcinogenesis 1996 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·Kimberly Lezon-Geyda,(unknown),James Godbold,(unknown),Aluko A. Hope,(unknown),(unknown),Hiroshi Uehara,Edward M. Johnson,Thomas M. Fasy	16

About Kimberly Lezon-Geyda

Kimberly Lezon-Geyda is a scholar working on Hematology, Cancer Research and Physiology, having authored 34 papers that have together received 860 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (10 papers), HER2/EGFR in Cancer Research (6 papers) and Genomics and Chromatin Dynamics (6 papers). The work is most often cited by research in Cancer Research (200 citations), Hematology (125 citations) and Genetics (112 citations). Kimberly Lezon-Geyda has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Vincent Schulz, Patrick G. Gallagher, Yelena Maksimova, Lyndsay N. Harris, Edyta Glogowska, Vesna Najfeld, EM Johnson, David Tuck, Archibald S. Perkins and Yi Zhang. Their work appears in journals such as Nucleic Acids Research, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact